Moleculin Biotech, Inc. — Director's Dealing 2020

Jun 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moleculin Biotech, Inc. (MBRX)
CIK: 0001659617
Period of Report: 2020-06-15

Reporting Person: George Robert E. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-15	Stock option (right to buy)	$1.12	A	15000	Acquired	2030-06-16	Common Stock (15000.0)	Direct

Footnotes

F1: (1) The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors in each vesting date.

F2: (2) The options were issued in connection with the reporting person's Board of Director service to the Company.